CPGR
  • Home
  • About Us
  • Services
    • Genomics
    • Proteomics
    • Routine Testing
    • Training
    • Bespoke Projects
    • Omics Start-up Accelerator
    • Terms of Service
  • FAQ
  • Register Project
  • Contact Us
Select Page

Can Genomics invigorate medical innovation on the African continent?

by Dr. Reinhard Hiller | Sep 22, 2014 | Blog, Emerging markets, Innovation management, The "Omics" Revolution

Yes! If a set of other components is in place to make a complex innovation equation work… Introduction Genomics holds great promises for drug development through the identification of new drug targets, better understanding of disease mechanism, and the elucidation of...

Can Genomics contribute to South Africa’s GDP? – A thought experiment with crude numbers…

by Dr. Reinhard Hiller | Sep 19, 2014 | Blog, Emerging markets, The "Omics" Revolution

My short answer to this is, yes, but the real value of Genomics goes beyond an economic return and cannot be captured easily in dollars and cents! Background According to US-based non-profit research organisation Battelle, the Human Genome Project (HGP) contributed...

Fixes that fail in ‘omics’ research and translation

by Dr. Reinhard Hiller | Jan 6, 2012 | Blog, The "Omics" Revolution

I have recently explored the development of the biggest Genomics facility in the world at present, the BGI in China, to contextualize what kind of role Africa can play in the ‘omics’ revolution. Here, I am starting to investigate some of the challenges the ‘omics’...

Can Africa play a role in the ‘omics’ revolution?

by Dr. Reinhard Hiller | Dec 21, 2011 | Blog, The "Omics" Revolution

Can Africa play a role in the ‘omics’ revolution? This is a question that I am being asked frequently by colleagues locally and internationally. If yes, what role could it be? I’d like to explore the role Africa can play through 3 different lenses: China’s role as an...

Constant gardeners – How we can stimulate innovation in emerging econcomies

by Dr. Reinhard Hiller | Dec 20, 2011 | Blog, The "Omics" Revolution

In a recent blog on Harvard Business Reviews online, Vijay Govindarajan and Justin Chakma argued that some VC firms operating in emerging economies follow a systems-based philosophy when making investment decisions. More specifically, some of these companies treat...

Recent Posts

  • Sars-CoV-2, unintended affects
  • Microbiome
  • Managing laboratory information in the cloud to support a rapid and scalable response to the Covid-19 pandemic in South Africa
  • CPGR, Artisan Biomed, together with partners, initiate CHIC (Cape Health Innovation Campus)
  • Artisan Biomed Partners with Cortex Group to Develop Pan-African Precision Medicine Solutions.

Recent Comments

    Archives

    • Jul 2020
    • Jun 2020
    • Apr 2020
    • Nov 2019
    • Jul 2019
    • Jun 2019
    • May 2019
    • Apr 2019
    • Feb 2019
    • Oct 2018
    • Sep 2018
    • Aug 2018
    • Apr 2018
    • Jan 2018
    • Nov 2017
    • Oct 2017
    • Sep 2017
    • Apr 2017
    • Oct 2016
    • Sep 2016
    • Apr 2016
    • Mar 2016
    • Feb 2016
    • Mar 2015
    • Sep 2014
    • Jul 2014
    • May 2014
    • Apr 2014
    • Dec 2013
    • Sep 2013
    • Aug 2013
    • Jul 2013
    • Jun 2013
    • Mar 2013
    • Nov 2012
    • Oct 2012
    • Jun 2012
    • Apr 2012
    • Mar 2012
    • Jan 2012
    • Dec 2011

    Categories

    • Announcement
    • Blog
    • Digital education
    • Emerging markets
    • Innovation management
    • Managerial practice
    • Online learning
    • Product launch
    • R&D productivity
    • The "Omics" Revolution
    • Uncategorized
    • VC financing

    Built by DevLabs | Maintained by DevLabs

    Click here for COVID-19 South Africa Coronavirus news and information portal